Research Report 2009
CIKA vice-president, Ellen Webb, produced the following image for fund-raising presentations. If you would like a representative of CIKA to make a presentation to your club or society on behalf of CIKA, email Ellen by clicking here.
Findings to date:
no adverse effects from dendritic cell vaccination;
objective clinical responses in five of the treated patients.
To date the trial has achieved the following results:
|Disease indication||Patients enrolled||Patients completed vaccines|
|Newly diagnosed stage 4 neuroblastoma||15||5|
|Recurrent solid tumours||4||2|
|Recurrent solid tumours||5||1|